Variable expression of congenital contractural arachnodactyly due to maternal mosaicism of a fibrillin-2 mutation

C. L. Clericuzio, M. Wang, M. Godfrey

Research output: Contribution to journalArticle

Abstract

Congenital contractural arachnodactyly (CCA) is an autosomal dominant connective tissue disorder which has been reported in over 120 individuals. Although the prognosis for typical CCA is good, a small number of infants with a severe, lethal form of CCA have been reported. These individuals have died from the sequelae of structural visceral anomalies, including interrupted aortic arch and duodenal atresia. While CCA has been linked to FBN2, the fibrillin gene on chromosome 5, no FBN2 mutations have been reported in CCA patients to date. Here we report a FBN2 mutation resulting in mis-splicing of exon 34, in a mother and daughter with CCA. While the mother exhibited the typical CCA phenotype with arachnodactyly, joint contractures and abnormal pinnae, her daughter exhibited the markedly more severe CCA phenotype, with additional visceral cardiac and gastrointestinal anomalies that led to death in infancy. RT-PCR studies suggest that the mother is a somatic mosaic for the mutation. However, all of the daughter's cells harbor the mutation. These data prove that FBN2 mutations can cause CCA, and also demonstrate phenotypic variability due to a dosage effect of a particularly deleterious FBN2 mutation. Based on the early expression pattern of fibrillin-2 during mouse embryogenesis, it is hypothesized that FBN2 mutations lead to visceral malformations by interfering with normal elastogenesis.

Original languageEnglish (US)
Pages (from-to)131A
JournalJournal of Investigative Medicine
Volume44
Issue number1
StatePublished - Jan 1 1996

Fingerprint

Mosaicism
Arches
Chromosomes
Ports and harbors
Exons
Genes
Mothers
Tissue
Mutation
Nuclear Family
Arachnodactyly
Phenotype
Fibrillin-2
Congenital contractural arachnodactyly
Chromosomes, Human, Pair 5
Contracture
Thoracic Aorta
Connective Tissue
Embryonic Development
Joints

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Variable expression of congenital contractural arachnodactyly due to maternal mosaicism of a fibrillin-2 mutation. / Clericuzio, C. L.; Wang, M.; Godfrey, M.

In: Journal of Investigative Medicine, Vol. 44, No. 1, 01.01.1996, p. 131A.

Research output: Contribution to journalArticle

@article{6014bc7bdd1e4e7f9f119233d02f6243,
title = "Variable expression of congenital contractural arachnodactyly due to maternal mosaicism of a fibrillin-2 mutation",
abstract = "Congenital contractural arachnodactyly (CCA) is an autosomal dominant connective tissue disorder which has been reported in over 120 individuals. Although the prognosis for typical CCA is good, a small number of infants with a severe, lethal form of CCA have been reported. These individuals have died from the sequelae of structural visceral anomalies, including interrupted aortic arch and duodenal atresia. While CCA has been linked to FBN2, the fibrillin gene on chromosome 5, no FBN2 mutations have been reported in CCA patients to date. Here we report a FBN2 mutation resulting in mis-splicing of exon 34, in a mother and daughter with CCA. While the mother exhibited the typical CCA phenotype with arachnodactyly, joint contractures and abnormal pinnae, her daughter exhibited the markedly more severe CCA phenotype, with additional visceral cardiac and gastrointestinal anomalies that led to death in infancy. RT-PCR studies suggest that the mother is a somatic mosaic for the mutation. However, all of the daughter's cells harbor the mutation. These data prove that FBN2 mutations can cause CCA, and also demonstrate phenotypic variability due to a dosage effect of a particularly deleterious FBN2 mutation. Based on the early expression pattern of fibrillin-2 during mouse embryogenesis, it is hypothesized that FBN2 mutations lead to visceral malformations by interfering with normal elastogenesis.",
author = "Clericuzio, {C. L.} and M. Wang and M. Godfrey",
year = "1996",
month = "1",
day = "1",
language = "English (US)",
volume = "44",
pages = "131A",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Variable expression of congenital contractural arachnodactyly due to maternal mosaicism of a fibrillin-2 mutation

AU - Clericuzio, C. L.

AU - Wang, M.

AU - Godfrey, M.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Congenital contractural arachnodactyly (CCA) is an autosomal dominant connective tissue disorder which has been reported in over 120 individuals. Although the prognosis for typical CCA is good, a small number of infants with a severe, lethal form of CCA have been reported. These individuals have died from the sequelae of structural visceral anomalies, including interrupted aortic arch and duodenal atresia. While CCA has been linked to FBN2, the fibrillin gene on chromosome 5, no FBN2 mutations have been reported in CCA patients to date. Here we report a FBN2 mutation resulting in mis-splicing of exon 34, in a mother and daughter with CCA. While the mother exhibited the typical CCA phenotype with arachnodactyly, joint contractures and abnormal pinnae, her daughter exhibited the markedly more severe CCA phenotype, with additional visceral cardiac and gastrointestinal anomalies that led to death in infancy. RT-PCR studies suggest that the mother is a somatic mosaic for the mutation. However, all of the daughter's cells harbor the mutation. These data prove that FBN2 mutations can cause CCA, and also demonstrate phenotypic variability due to a dosage effect of a particularly deleterious FBN2 mutation. Based on the early expression pattern of fibrillin-2 during mouse embryogenesis, it is hypothesized that FBN2 mutations lead to visceral malformations by interfering with normal elastogenesis.

AB - Congenital contractural arachnodactyly (CCA) is an autosomal dominant connective tissue disorder which has been reported in over 120 individuals. Although the prognosis for typical CCA is good, a small number of infants with a severe, lethal form of CCA have been reported. These individuals have died from the sequelae of structural visceral anomalies, including interrupted aortic arch and duodenal atresia. While CCA has been linked to FBN2, the fibrillin gene on chromosome 5, no FBN2 mutations have been reported in CCA patients to date. Here we report a FBN2 mutation resulting in mis-splicing of exon 34, in a mother and daughter with CCA. While the mother exhibited the typical CCA phenotype with arachnodactyly, joint contractures and abnormal pinnae, her daughter exhibited the markedly more severe CCA phenotype, with additional visceral cardiac and gastrointestinal anomalies that led to death in infancy. RT-PCR studies suggest that the mother is a somatic mosaic for the mutation. However, all of the daughter's cells harbor the mutation. These data prove that FBN2 mutations can cause CCA, and also demonstrate phenotypic variability due to a dosage effect of a particularly deleterious FBN2 mutation. Based on the early expression pattern of fibrillin-2 during mouse embryogenesis, it is hypothesized that FBN2 mutations lead to visceral malformations by interfering with normal elastogenesis.

UR - http://www.scopus.com/inward/record.url?scp=33749575133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749575133&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749575133

VL - 44

SP - 131A

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 1

ER -